OCWP
RCKT icon

Owl Creek Wealth Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Owl Creek Wealth Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Hold
1,300
– – ﹤0.01% 1055
2026
Q1 		$4.65K Buy
+1,300
New +$5.17K ﹤0.01% 988

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Owl Creek Wealth Partners's RCKT Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 1,300 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Owl Creek Wealth Partners first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.65K in Q1 2026. 164 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Owl Creek Wealth Partners held 1,300 shares of Rocket Pharmaceuticals worth $4.45K as of Q2 2026.
  • Owl Creek Wealth Partners left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #1055 holding.
  • Owl Creek Wealth Partners first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Rocket Pharmaceuticals position peaked at $4.65K in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.